Elsevier Vice Chairman Chi to lead Science & Technology Division
Herman van Campenhout to join a Dutch company as CEO
Amsterdam, 4 December 2009 - Elsevier announced today the appointment of Youngsuk “Y.S.” Chi, the company’s Vice Chairman, to serve as Chief Executive Officer of Elsevier’s Science & Technology (S&T) Division. The appointment follows the decision by division CEO Herman van Campenhout to accept a new position as CEO of a publicly listed Dutch company early next year. “We wish Herman every success in his new job and thank him for his contributions,” said Reed Elsevier CEO Erik Engstrom.
“Elsevier Science & Technology has a clear strategy and a strong management team. We are very fortunate that our Vice Chairman can step in immediately as CEO of S&T to help that team continue to build on its successful track record,” said Engstrom. Chi will continue to report directly to Engstrom.
Chi, 48, has been Vice Chairman of Elsevier for almost five years. During that time he has led the company’s Global Academic & Customer Relations efforts and has been deeply engaged in S&T’s business. He has more than 15 years of management experience in publishing and technology.
Chi will also continue to serve on the Reed Elsevier Management Committee and to oversee government affairs for Reed Elsevier.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+31 20 485 3269